HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long Yu Selected Research

Drug Therapy (Chemotherapy)

1/2021Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis.
3/2016Totally implantable venous access port systems and associated complications: A single-institution retrospective analysis of 2,996 breast cancer patients.
2/2015Dietary fucoidan of Acaudina molpadioides and its enzymatically degraded fragments could prevent intestinal mucositis induced by chemotherapy in mice.
4/2014Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function.
12/2012Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells.
3/2008Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Long Yu Research Topics

Disease

133Neoplasms (Cancer)
03/2024 - 01/2001
69Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2003
18Carcinogenesis
08/2023 - 03/2005
16Neoplasm Metastasis (Metastasis)
11/2022 - 01/2002
15Breast Neoplasms (Breast Cancer)
01/2021 - 07/2010
14Carcinoma (Carcinomatosis)
10/2009 - 01/2002
12Liver Neoplasms (Liver Cancer)
01/2023 - 01/2002
12Infections
01/2022 - 01/2004
7Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 09/2009
7Stroke (Strokes)
01/2023 - 11/2009
7Esophageal Neoplasms (Esophageal Cancer)
01/2016 - 01/2002
6Hypoxia (Hypoxemia)
08/2023 - 01/2002
6Stomach Neoplasms (Stomach Cancer)
07/2021 - 01/2015
5Osteoporosis
11/2023 - 06/2013
5Fibrosis (Cirrhosis)
10/2023 - 04/2003
5Lung Neoplasms (Lung Cancer)
01/2023 - 02/2013
4Babesiosis (Piroplasmosis)
01/2020 - 01/2017
4Prostatic Neoplasms (Prostate Cancer)
09/2017 - 02/2014
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 08/2011
3COVID-19
03/2022 - 01/2021
3Osteosarcoma (Osteogenic Sarcoma)
11/2020 - 10/2011
3Adenocarcinoma
01/2018 - 01/2017
3Starvation
05/2013 - 01/2009
2Spondylosis
05/2023 - 06/2017
2Anthrax
01/2023 - 01/2022
2Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 01/2004
2Inflammation (Inflammations)
11/2022 - 01/2021
2Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2021
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 01/2021
2Reperfusion Injury
01/2022 - 01/2021
2Postmenopausal Osteoporosis
12/2021 - 01/2019
2Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2021 - 01/2021
2Pathologic Processes
12/2020 - 05/2019

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2002
25Biomarkers (Surrogate Marker)IBA
11/2023 - 04/2003
20Messenger RNA (mRNA)IBA
12/2020 - 01/2002
13MicroRNAs (MicroRNA)IBA
05/2022 - 07/2010
11AntigensIBA
11/2023 - 05/2002
10RNA (Ribonucleic Acid)IBA
01/2023 - 03/2005
9DNA (Deoxyribonucleic Acid)IBA
11/2020 - 04/2003
9ORALIT (ORS)IBA
04/2012 - 07/2010
8Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
03/2024 - 10/2011
8Monoclonal AntibodiesIBA
01/2023 - 07/2006
7Long Noncoding RNAIBA
06/2023 - 12/2012
6Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2019 - 06/2007
6AntibodiesIBA
01/2019 - 05/2002
6EnzymesIBA
01/2018 - 01/2002
6Complementary DNA (cDNA)IBA
05/2008 - 05/2002
5Histones (Histone)IBA
08/2023 - 08/2012
4CateninsIBA
10/2023 - 06/2012
4Phosphotransferases (Kinase)IBA
01/2022 - 02/2010
4Codon (Codons)IBA
12/2020 - 04/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2002
4IntegrinsIBA
12/2018 - 01/2009
4Aurora KinasesIBA
02/2015 - 03/2010
4Aurora Kinase BIBA
01/2015 - 08/2012
4Amino AcidsFDA Link
07/2014 - 02/2002
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2014 - 10/2010
4Protein Kinases (Protein Kinase)IBA
12/2013 - 02/2010
4arginylarginine (Arg-Arg)IBA
04/2012 - 09/2010
4CytokinesIBA
02/2012 - 10/2010
3Immunoglobulin G (IgG)IBA
11/2023 - 05/2008
3Peptides (Polypeptides)IBA
11/2023 - 05/2011
3Interleukin-6 (Interleukin 6)IBA
07/2022 - 07/2017
3Therapeutic UsesIBA
01/2022 - 02/2012
3Fluorouracil (Carac)FDA LinkGeneric
09/2021 - 01/2018
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2019 - 07/2010
3Small Interfering RNA (siRNA)IBA
01/2018 - 05/2014
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2018 - 04/2012
3Caspase 3 (Caspase-3)IBA
01/2017 - 10/2012
3Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2016 - 01/2004
3Carcinoembryonic AntigenIBA
06/2016 - 05/2002
3HLA-DQ Antigens (HLA-DQ)IBA
11/2015 - 01/2013
3Cyclin D1IBA
01/2015 - 06/2012
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 03/2010
3Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
01/2015 - 03/2006
3prolyl-proline (Pro-Pro)IBA
12/2011 - 09/2010
3arginylprolineIBA
12/2011 - 09/2010
3SeptinsIBA
10/2010 - 02/2006
3Matrix Metalloproteinases (MMPs)IBA
07/2010 - 01/2009
2AutoantibodiesIBA
11/2023 - 05/2008
2CurcuminIBA
12/2022 - 04/2018
2ErbB Receptors (EGF Receptor)IBA
12/2022 - 01/2015
2C-Reactive ProteinIBA
07/2022 - 09/2007
2Phosphopyruvate Hydratase (Enolase)IBA
12/2021 - 10/2020
2Voltage-Gated Sodium ChannelsIBA
09/2021 - 01/2021
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2021 - 03/2016
2ElementsIBA
07/2021 - 01/2014
2Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 06/2012
2GlucocorticoidsIBA
01/2021 - 01/2021
2CyclinsIBA
12/2020 - 01/2020
2RNA-Binding Proteins (RNA-Binding Protein)IBA
12/2020 - 01/2020
2Circular RNAIBA
11/2020 - 01/2019
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2020 - 07/2016

Therapy/Procedure

48Therapeutics
03/2024 - 01/2001
6Drug Therapy (Chemotherapy)
01/2021 - 03/2008
6Hepatectomy
11/2020 - 07/2016
3Neoadjuvant Therapy
01/2022 - 01/2019
2Qigong (Qi Gong)
07/2021 - 01/2021
2Activities of Daily Living (ADL)
01/2021 - 03/2020